News & Views | Published:

A radical approach to cancer

References

  1. 1

    Nicolaou, K.C., Maligres, P., Shin, J., de Leon, E. & Rideout, D. J. Am. chem. Soc. 112, 7825–7826 (1990).

  2. 2

    Nicolaou, K.C. et al. Angew. Chem. Int. Ed. Engl. 29, 1064–1067 (1990).

  3. 3

    Lee, M.D. et al. J. Am. chem. Soc. 109, 3464–3466 (1987).

  4. 4

    Golik, J. et al. J. Am. chem. Soc. 109, 3462–3464 (1987).

  5. 5

    Zein, N., Sinha, A.M., GcGahren, W.J. & Ellestad, G.A. Science 240, 1198–1201 (1988).

  6. 6

    Connors, T.A. in Cancer Chemotherapy and Biological Response Modifiers, Annual 11 (eds Pinedo, H.M., Longo, D.L. & Chabner, B.A.) 29–44 (Elsevier, Amsterdam, 1990).

  7. 7

    Edo, K. et al. Tetrahedron Lett. 20, 331–334 (1985).

  8. 8

    Golik, J., Doyle, T.W., van Duyne, G. & Clardy, J. Tetrahedron Lett. 31, 6149–6150 (1990).

  9. 9

    Menendez, A. et al. 4th International Conference on Monoclonal Antibody Immunoconjugates for Cancer, 1–75, UCSD Cancer Center, San Diego, California, March-April 1989.

  10. 10

    Tomioka, K., Fujita, H. & Koga, K. Tetrahedron Lett. 30, 851–854 (1989).

  11. 11

    Nicolaou, K.C. et al. J. Am. chem. Soc. 112, 8193–8195 (1990).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.